PT-796

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePT-796

Drug Alias NamePT-796

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionFolate receptor alpha antagonistsCluster of differentiation 47 inhibitors

TargetsFolate receptor alphaCluster of differentiation 47

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPhanes Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesPhanes Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A